Revista Científica de la Sociedad Española de Medicina de Urgencias y Emergencias
Subscríbete a nuestra newsletter
Factor de impacto 2022
5.5
1er cuartil (4 de 32)
Emergency Medicine
Resumen
Perlas para urgenciólogos
381-3
35
5
Octubre
2023
381
383
Download in PDF < Volver
La ivermectina para la prevención y el tratamiento de la COVID-19
Popp M, Reis S, Schieber S, Hausinger RI, Stegemann M, Metzendorf MI, Kranke P, Meybohom P, Skoetz N, Weibel S
X1 Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg, Wuerzburg, Alemania. Department of Nephrology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Alemania. Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Alemania. Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Duesseldorf, Düsseldorf, Alemania. Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Alemania.
Síguenos en:
